222
Participants
Start Date
January 15, 2019
Primary Completion Date
June 19, 2023
Study Completion Date
June 19, 2023
Golimumab
Participants will receive golimumab as a part of clinical practice.
Peak Medical Specialty Centre, Calgary
Jacqueline C Stewart Medical Inc., Penticton
Dr. Milton F Baker Inc., Victoria
Fredericton Medical Clinic, Fredericton
Nexus Clinical Research, St. John's
St Clare's Hospital, St. John's
Private Practice - Dr. Diane Wilson, Lunenburg
The Waterside Clinic, Barrie
Dr. Sankalp V. Bhavsar Medicine Professional Corporation, Burlington
Private Practice - Dr. Pauline Boulos, Dundas
Dr. Sangeetha Thiviyarajah Medicine Professional Corporation, Etobicoke
Samuel Silverberg Medicine Professional Corporation, Etobicoke
Adachi Medicine Professional Corporation, Hamilton
Manisha Mulgund Medicine Professional Corporation, Hamilton
K-W Musculoskeletal Research Inc, Kitchener
Markham Rheumatology Hub, Markham
Credit Valley Rheumatology, Mississauga
Dr. Rajwinder S Dhillon Medicine Professional Corporation, Niagara Falls
Makhzoum Medicine Professional Coporation, Oakville
Dr. S. Gill Medicine Professional Corporation, Oakville
Dr. Abraham Chaiton Medicine Professional Corporation, Toronto
Sunnybrook Regional Cancer Centre, Toronto
Arthur Karasik Medicine Professional Corporation, Toronto
Dr. Sabeen Anwar Medicine Professional Corporation, Windsor
Clinique de Rhumatologie de Montreal, Montreal
Private Practice Dr Louis Bessette, Québec
Centre de sante et services sociaux (CSSS) de Rimouski-Neigette - Hopital regional - Rimouski, Rimouski
CIUSSS de L Estrie CHUS, Sherbrooke
Clinique Jacques Cartier- Rheumatology Division - Université de Sherbrooke, Sherbrooke
Centre de Recherche Musculo Squelettique, Trois-Rivières
Community Rheumatology Care, Saskatoon
Rheumatology Associates of Saskatoon, Saskatoon
Janssen Inc.
INDUSTRY